Pharmaceutical

Pharma M&A: The top high value deals in 2023

From Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma deals that were completed in 2023.

Jun 26, 2024 - 04:00
Pharma M&A: The top high value deals in 2023
From Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma deals that were completed in 2023.
Read the original article

Tags:

Previous Article

Magazine: UK’s new Netflix-style funding model for antibiotics goes live

Next Article

Medical packaging companies in pharmaceutical contract manufacturing 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more

STAT+: Pharmalittle: We’re reading about kids taking We...

Feb 17, 2024

Opinion: Former U.S. surgeons general: The U.S. should ban menthol cigarettes

Opinion: Former U.S. surgeons general: The U.S. should ...

Feb 9, 2024

Rafael Holdings and Cyclo Therapeutics enter merger deal

Rafael Holdings and Cyclo Therapeutics enter merger deal

Aug 25, 2024